Bottom line
What does BBH hold?
BBH held 25 positions as of Jun 30, 2026. Its largest holding is Amgen Inc at 15.25% of the fund, and the top 10 positions add up to 70.3%. By asset type it is 100% stocks, 0% cash & short-term funds.
Updated Aug 26, 2026
BBH top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Amgen Inc | Stocks | 15.25% | $60.3M |
| 2 | Gilead Sciences Inc | Stocks | 12.79% | $50.6M |
| 3 | Vertex Pharmaceuticals Inc | Stocks | 9.10% | $36.0M |
| 4 | Regeneron Pharmaceuticals Inc | Stocks | 6.21% | $24.6M |
| 5 | Revolution Medicines Inc | Stocks | 5.27% | $20.9M |
| 6 | Argenx SE | Stocks | 4.97% | $19.7M |
| 7 | Natera Inc | Stocks | 4.92% | $19.5M |
| 8 | IQVIA Holdings Inc | Stocks | 4.31% | $17.0M |
| 9 | Alnylam Pharmaceuticals Inc | Stocks | 3.83% | $15.2M |
| 10 | Biogen Inc | Stocks | 3.63% | $14.3M |
| 11 | Moderna Inc | Stocks | 3.36% | $13.3M |
| 12 | Illumina Inc | Stocks | 3.17% | $12.5M |
| 13 | United Therapeutics Corp | Stocks | 2.83% | $11.2M |
| 14 | BeOne Medicines Ltd | Stocks | 2.81% | $11.1M |
| 15 | Insmed Inc | Stocks | 2.67% | $10.6M |
| 16 | Incyte Corp | Stocks | 2.49% | $9.9M |
| 17 | Neurocrine Biosciences Inc | Stocks | 2.08% | $8.2M |
| 18 | BioNTech SE | Stocks | 1.94% | $7.7M |
| 19 | Icon Plc | Stocks | 1.90% | $7.5M |
| 20 | Bio-Techne Corp | Stocks | 1.54% | $6.1M |
| 21 | Charles River Laboratories International Inc | Stocks | 1.50% | $5.9M |
| 22 | BioMarin Pharmaceutical Inc | Stocks | 1.34% | $5.3M |
| 23 | Qiagen Nv | Stocks | 1.06% | $4.2M |
| 24 | Tempus AI Inc | Stocks | 0.98% | $3.9M |
| 25 | State Street Global Advisors State Street Navigator Securities Lending Government Money… |
Cash & short-term funds | 0.06% | $233.7K |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 26, 2026